dr bennett's semaglutide Dr. John Bennett, MD Semaglutide for Weight Loss: What

These effects can leave you feeling fuller for longer and less hungry than usual, which can lead to reduced caloric intake and ultimately promote weight loss

In a randomized, single-blind, 24-week study, participants assigned to dual therapy of 2 mg weekly of the GLP-1 receptor agonist exenatide (Bydureon, AstraZeneca) and 10 mg daily of the SGLT2 inhibitor dapagliflozin (Farxiga, AstraZeneca) lost more weight than those taking either agent alone or those receiving dapagliflozin and metformin extended-release (Xigduo XL, AstraZeneca) or phentermine/topiramate extended-release (Qsymia, Vivus)

Many companies were facing long lead times, inconsistent support, and equipment that failed to meet the demands of their process

GLP-1s were also tied to lower risks for preterm and cesarean births